Pharmafile Logo
Pharmafocus logo
Advanced Search

metastic cancer

Showing 1 posts of 1 posts found.

CuraCell granted approval for trial of new therapy for metastatic cancers

August 13, 2025
Research and Development CuraCell, Immunology, clinical trial, immunotherapy, metastic cancer

Swedish immunotherapy company, CuraCell, has received approval from the Paul-Ehrlich-Institut in Germany to begin a phase 1/2a clinical trial of …

News
The Gateway to Local Adoption Series

Latest content

Survey highlights mental health burden among rare disease patients and families

November 5, 2026

Addressing the rheumatic disease diagnostic gap in primary care

November 5, 2026

How chronic disease creates opportunity on diagnostic and therapeutic pipelines

November 4, 2026

EnteroBiotix appoints former GSK Chief Medical Officer to board

November 3, 2026

Stryker invests US$400m in CMR Surgical and secures option to acquire business

November 3, 2026